1. Home
  2. Analysis
  3. Micardis
  4. Blindness

Micardis and Blindness - a phase IV clinical study of FDA data

Summary:

Blindness is reported as a side effect among people who take Micardis (telmisartan), especially for people who are female, 60+ old, also take Amlodipine, and have Acromegaly.

The phase IV clinical study analyzes which people have Blindness when taking Micardis. It is created by eHealthMe based on reports of 26,556 people who have side effects when taking Micardis from the FDA, and is updated regularly.

What is Micardis?

Micardis has active ingredients of telmisartan. It is often used in high blood pressure. eHealthMe is studying from 27,605 Micardis users. Check the latest studies of Micardis.

What is Blindness?

Blindness is found to be associated with 1,509 drugs and 1,987 conditions by eHealthMe. Check the latest studies of Blindness.

On Jul, 03, 2026

26,556 people reported to have side effects when taking Micardis.
Among them, 90 people (0.34%) have Blindness.

Could Micardis cause Blindness?

Among these 90 people:

What is the gender of people who have Blindness when taking Micardis? *

  • female: 69.66 %
  • male: 30.34 %

What is the age of people who have Blindness when taking Micardis? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 1.27 %
  • 40-49: 0.0 %
  • 50-59: 10.13 %
  • 60+: 88.61 %

What are other drugs people take besides Micardis? *

  1. Amlodipine: 23 people, 25.56%
  2. Gliclazide: 22 people, 24.44%
  3. Linagliptin: 22 people, 24.44%
  4. Metformin: 21 people, 23.33%
  5. Sinemet: 14 people, 15.56%
  6. Signifor Lar: 13 people, 14.44%
  7. Sandostatin: 10 people, 11.11%
  8. Plendil: 9 people, 10.00%
  9. Diclofenac: 9 people, 10.00%
  10. Novolog: 8 people, 8.89%

What are other side effects people have besides Blindness? *

  1. Hypotension (abnormally low blood pressure): 40 people, 44.44%
  2. Fall: 38 people, 42.22%
  3. Dizziness: 35 people, 38.89%
  4. Confusional State: 35 people, 38.89%
  5. Blood Glucose Increased: 32 people, 35.56%
  6. Memory Loss: 31 people, 34.44%
  7. Stress And Anxiety: 31 people, 34.44%
  8. Weight Decreased: 30 people, 33.33%
  9. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 28 people, 31.11%
  10. Head Injury: 28 people, 31.11%

What are the existing conditions these people have? *

  1. Acromegaly (body produces too much growth hormone, leading to excess growth of body tissues): 25 people, 27.78%
  2. Type 2 Diabetes: 24 people, 26.67%
  3. Parkinson's Disease: 14 people, 15.56%
  4. Brain Neoplasm (tumour of brain): 9 people, 10.00%
  5. Blood Glucose Abnormal: 6 people, 6.67%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 6.67%
  7. Ill-Defined Disorder: 6 people, 6.67%
  8. Osteoporosis (bones weak and more likely to break): 6 people, 6.67%
  9. Immune System Disorder: 6 people, 6.67%
  10. Diabetes: 5 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Micardis and have Blindness?

- Check whether Blindness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Micardis:

Blindness treatments and more:

How severe was Blindness and when was it recovered:

Expand to all the drugs that have ingredients of telmisartan:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Micardis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Blindness:

Browse all the conditions that are associated with Blindness:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on telmisartan (the active ingredients of Micardis) and Micardis (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.